Thyroid Gland Papillary Carcinoma

general

A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the n

Centers

Active Trials

$539M

Cancer Funding

Specific Cancer Types(3)

Name	Centers	Active Trials
Tall Cell Variant Thyroid Gland Papillary Carcinoma	13	10
Follicular Variant Thyroid Gland Papillary Carcinoma	12	10
Columnar Cell Variant Thyroid Gland Papillary Carcinoma	4	—

Top Centers for Thyroid Gland Papillary Carcinoma(14)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
2	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
3	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
4	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
5	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
6	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
7	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
8	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	3	—	56.6
9	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	3	—	56.6
10	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	3	—	56.6
11	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	34.1
12	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	$319M	—
13	University of Illinois Cancer CenterChicago, IL		—	$122M	—
14	Boston University Cancer CenterBoston, MA		—	$98M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →